The QualityStocks Daily Tuesday, November 18th, 2025

Today's Top 3 Investment Newsletters

MarketClub Analysis(OLMA) $20.1400 +136.39%

Green Car Stocks(WKHS) $0.7587 +37.65%

SmallCapSociety(NWTG) $1.1500 +27.18%

The QualityStocks Daily Stock List

Forte Biosciences (FBRX)

MarketBeat, TradersPro, FreeRealTime, Schaeffer's, QualityStocks, StreetInsider, StockMarketWatch and InsiderTrades reported earlier on Forte Biosciences (FBRX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Forte Biosciences Inc. (NASDAQ: FBRX) (FRA: 37TA) is a clinical-stage biopharmaceutical firm that is engaged in the development of treatments for various dermatological indications.

The firm has its headquarters in Torrance, California and was incorporated in 2017, by Paul A. Wagner. Prior to its name change, the firm was known as Tocagen. It serves consumers in the United States.

The company is focused on developing a live bio-therapeutic for the treatment of various inflammatory skin illnesses like pediatric and adult atopic dermatitis. The skin is a barrier organ that’s characterized by the interaction between the host tissue and microbial communities through signaling offered by the adaptive and innate immune systems. Being exposed to different exogenous and endogenous factors affects the system’s balance, which is what causes inflammatory skin conditions made up of autoimmune ailments, allergies or infections.

The enterprise’s product pipeline comprises of a topically applied live bio-therapeutic that was developed in collaboration with the National Institute of Allergy and Infectious Diseases and the National Institutes of Health, for the treatment of inflammatory skin diseases. The bio-therapeutic, dubbed FB-401, has concluded phase I testing in pediatric and adult patients who suffer from atopic dermatitis. The enterprise has advanced the candidate into a randomized phase II clinical trial.

Forte Biosciences (FBRX), closed Tuesday's trading session at $17.97, up 24.0166%, on 89,937 volume. The average volume for the last 3 months is 22,610 and the stock's 52-week low/high is $4.9/$28.68.

Graphite One (GPHOF)

QualityStocks and TradersPro reported earlier on Graphite One (GPHOF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Graphite One, Inc. (OTCQX: GPHOF) (CVE: GPH) (FRA: 2JCA) is a mineral exploration firm that is focused on exploring for, acquiring and evaluating graphitic mineral properties.

The firm has its headquarters in Vancouver, Canada and was incorporated in 2006, on March 16th. Prior to its name change in February 2019, the firm was known as Graphite One Resources Inc. It operates as part of the other industrial metals and mining industry, under the renewable energy and basic materials sectors. The firm serves clients and consumers in Canada.

The company is focused on the production of a range of graphite applications, as well as on the production of anode material for the Li-ion electric car battery market and energy storage systems market.

The enterprise holds interest in the Graphite Creek property, which comprises of 176 mining claims which cover an area of about 9,580 hectares situated on Alaska’s Seward Peninsula. Through its subsidiary, the enterprise is evaluating resources on its Graphite Creek property, which is situated roughly 60km north of Nome, Alaska. This project is seen as a vertically integrated enterprise for mining, processing and manufacturing CSG (coated spherical graphite). The enterprise is also evaluating the establishment of a manufacturing facility for graphite products using graphite extracted from this property.

Graphite One (GPHOF), closed Tuesday's trading session at $1.05, up 23.5963%, on 1,878,235 volume. The average volume for the last 3 months is 9,787,516 and the stock's 52-week low/high is $0.432/$1.64.

Brookmount Explorations, Inc. (BMXI)

QualityStocks, Penny Picks, Damn Good Penny Picks, DSR News, Penny Stock Titans, Trading Wall St, OTCBB Journal, Shiznit Stocks, Penny Stock General, ProTrader, First Penny Picks, InvestorPlace, Monster Alerts, Nebula Stocks, Penny Stock 101, PennyStockLocks, PoliticsAndMyPortfolio, Winston Small Cap, Real Pennies, Small Cap Firm, SmallCapVoice, StockRockandRoll, StocksImpossible, StockTradingNetwork, TheMicrocapNews, Wall Street Resources and PHUB News reported earlier on Brookmount Explorations, Inc. (BMXI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A Nevada incorporated company, Brookmount Explorations, Inc. (BMXI) presently owns and operates two gold production facilities in Northern Indonesia. The Company is also in the process of reviewing acquisitions of additional operations in Indonesia and the Philippines. It is targeting the acquisition of high quality assets consisting of gold reserves that can undergo development via rapid and efficient deployment of technology and converted into cash flow to finance further expansion. Brookmount Explorations has its corporate headquarters in Los Angeles, California. It has also established an office in Melbourne, Australia and is seeking opportunities in what is one of the world’s leading gold producers. The Company lists on the OTC Markets.

At the end of August 2020, Brookmount Explorations, Inc. announced that it received consent from its Board of Directors that, subject to receipt of approval of a majority of the Company's shareholders, the name of the Company would be changed to Brookmount Gold Corporation from Brookmount Explorations, Inc. to reflect the Company’s status more accurately as an active operator and producer in the gold mining sector.

Brookmount Explorations’ existing operations consist of two key sites. One is Talawaan. This is a 50 hectare reserve and onsite processing facility situated in a high grade volcanic hosted sediment body in the district of Talawaan, next to the airport at Manado, regional capital. The facility has been in operation for 10 years. It has recently been upgraded and expanded. It consists of ball mills (ore crushers), 5 high capacity floatation tanks, tailing ponds, as well as off site smelting operations.

The Company also has a second site west of Manado with 2 contiguous areas totalling roughly 17 HA of high grade volcanic hosted ore. This site has also commenced production. Average ore grade of this property is in excess of 1.5g/tonne.

Brookmount Explorations, Inc. (BMXI), closed Tuesday's trading session at $0.0237, up 14.3822%, on 7,018,087 volume. The average volume for the last 3 months is 6,556,795 and the stock's 52-week low/high is $0.00646/$0.06908.

Aligos Therapeutics (ALGS)

QualityStocks, MarketBeat, TradersPro, StockEarnings, Prism MarketView, Premium Stock Alerts, Penny Stock and InsiderTrades reported earlier on Aligos Therapeutics (ALGS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Aligos Therapeutics Inc. (NASDAQ: ALGS) (FRA: 5WK) is a clinical-stage biopharmaceutical firm that is engaged in the development of new therapeutics that address unmet medical needs for various indications.

The firm has its headquarters in San Francisco, California and was incorporated in 2018, on February 5th by Lawrence M. Blatt and Lucinda Quan. It operates as part of the medical and diagnostic laboratories industry, under the health care sector. The firm has two companies in its corporate family and serves consumers around the globe, with a focus on the United States.

The company is party to a research partnership with VipergenApS, which entails the development of its DEL-based (DNA Encoded Library) drug discovery system for liver illnesses and viral infections. The company is also party to a license and collaboration agreement with Luxna Biotech Co. Ltd, for the development and commercialization of products which contain oligonucleotides that target SARS-CoV-2. In addition to this, it is party to a research, licensing and commercialization agreement with Katholieke Universiteit Leuven, which entails the development of coronavirus protease inhibitors.

The enterprise’s product pipeline is comprised of a small molecule agonist dubbed ALG-055009, which has been developed to treat non-alcoholic steatohepatitis; an antisense oligonucleotide dubbed ALG-020572, indicated for decreasing HBsAg levels; and a capsid assembly modulator known as ALG-000184, which is undergoing phase 1 clinical trials evaluating its effectiveness in treating chronic hepatitis B. It also develops a synthetic oligonucleotide dubbed ALG-010133 for the treatment of chronic hepatitis B. In addition to this, the enterprise develops ALG-125819, ALG-125097 and ALG-125755.

Aligos Therapeutics (ALGS), closed Tuesday's trading session at $7.92, up 12.8205%, on 113,034 volume. The average volume for the last 3 months is 659,125 and the stock's 52-week low/high is $3.76/$46.8.

Innovus Pharmaceuticals, Inc. (INNV)

QualityStocks, MarketBeat, SeeThruEquity Research, Wall Street Mover, Profitable Trader Authority, Penny Pick Finders, Buzz Stocks, Emerging Markets, Fortune Stock Alerts, StockOnion, PennyStockProphet, TopPennyStockMovers, PennyStockScholar, OTCtipReporter, Planet Penny Stocks, DSR News, PennyPickAlerts, FreeRealTime, Streetwise Reports, StreetInsider, Promotion Stock Secrets, BUYINS.NET, TipRanks, StockRockandRoll, StockMister, HotTopPennyStocks, StockMarketQuote.us, PennyStockLocks, MarketClub Analysis, Zacks, OTPicks, PoliticsAndMyPortfolio, Penny Stock 101, Penny Stock Bets, Penny Stock Circle, Penny Stock Hub, 1-2-3 Stock Alerts, PHUB News and Marketbeat.com reported earlier on Innovus Pharmaceuticals, Inc. (INNV), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Innovus Pharmaceuticals, Inc. is an emerging commercial-stage pharmaceutical company based in San Diego, California. The Company delivers safe, innovative and effective over-the-counter (OTC) medicine and consumer care products to improve men’s and women's health and respiratory diseases. Its dedication is to being a leader in developing and marketing new OTC and branded Abbreviated New Drug Application (ANDA) products. Established in 2008, Innovus Pharmaceuticals lists on the OTCQB.

The Company is pursuing opportunities where existing prescription drugs have recently, or are expected to, change from prescription (Rx) to OTC. Innovus delivers unique and innovatively presented and packaged health solutions via its OTC medicines and consumer and health products that it markets directly, via commercial partners to primary care physicians, urologists, gynecologists and therapists, and directly to consumers via its on-line channels, retailers and wholesalers.

Innovus Pharmaceuticals has products for a range of indications. These include Brain Health, Diabetes, Fertility, Men’s Health, Pain Management, Respiratory, Vitality, Vision, and Women’s Health.

Innovus Pharmaceuticals, Inc. (INNV), closed Tuesday's trading session at $5.59, up 12.4748%, on 262,525 volume. The average volume for the last 3 months is 95,860 and the stock's 52-week low/high is $2.6/$6.26.

Can Fite Biopharma (CANF)

RedChip, StockMarketWatch, Streetwise Reports, BUYINS.NET, QualityStocks, INO.com Market Report, MarketClub Analysis, MarketBeat, Stock Analyzer, OTCBB Journal, StockEarnings, First Penny Picks, StocksImpossible, StreetInsider, PennyStockProphet, Broad Street, TradersPro, StockOodles, Jason Bond, InvestorPlace, CRWEFinance, Marketbeat.com, InvestorsUnderground, HotOTC, Buzz Stocks, CRWEPicks, CRWEWallStreet, DrStockPick, Investing Futures, Red Chip, Weekly Newsletter, WealthMakers, Top Stock Picks, TipRanks, The Street, The Stock Dork, Street Insider, PennyOmega, StockHotTips, OTC Journal, Profitable Trader Authority, PennyToBuck, Zacks, PennyStockScholar, BestOtc, Penny Pick Finders, OTCtipReporter and StockOnion reported earlier on Can Fite Biopharma (CANF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Can Fite Biopharma Ltd. (NYSE American: CANF) (FRA: CF5B) (TLV: CANF) is a clinical-stage biopharmaceutical firm that is engaged in developing small molecule therapeutic products used to treat erectile dysfunction and inflammatory ailments as well as liver disease and cancer.

The firm has its headquarters in Petach-Tikva, Israel and was incorporated in 1994, on September 11th by Ilan Cohn and Pnina Fishman. Prior to its name change in January 2001, the firm was known as Can-Fite Technologies Ltd.

The company is party to a collaboration agreement with Univo Pharmaceuticals which entails the identification and co-development of formulations of marijuana components for the treatment of metabolic, autoimmune and inflammatory diseases, as well as cancer. It also has a collaboration agreement with CMS Medical which entails the development, manufacture and commercialization of its Namodenoson and Piclidenoson formulations.

The enterprise’s candidates include CF602, which is in preclinical trial for erectile dysfunction treatment; and, Namodenoson (CF102), which is in a phase 2 trial for treating non-alcoholic steatohepatitis and has concluded phase 2 clinical trials evaluating its effectiveness in treating hepatocellular carcinoma. It also develops Piclidenoson (CF101), which is undergoing phase 2 trials for the treatment of the coronavirus and phase 3 clinical trials for psoriasis treatment. The enterprise is also engaged in the development of predictive biomarker blood test kits for A3AR.

Can Fite Biopharma (CANF), closed Tuesday's trading session at $0.3801, up 5%, on 355,712,902 volume. The average volume for the last 3 months is 12,351,720 and the stock's 52-week low/high is $0.3503/$2.35.

Kinetic Seas (KSEZ)

We reported earlier on Kinetic Seas (KSEZ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Kinetic Seas Inc. (OTCQB: KSEZ) is an AI consulting, research and development, infrastructure, and software firm.

The firm has its headquarters in Schaumburg, Illinois and was incorporated in 2015. It operates as part of the information technology services industry, under the technology sector. The company serves consumers in the United States.

Kinetic Seas was built by AI/ML engineers with a proven track record of AI development, hosting, and implementation for Business. It envisions a future where data science, machine learning, and artificial intelligence are tightly integrated into the operations and workflow of every company.

The enterprise offers artificial intelligence research and development, and software solutions in the United States. It offers consulting services, such as strategic consulting, project execution, and infrastructure planning; training and education services, including custom-designed training for enterprise clients; product development; and partnerships and incubation services.

Kinetic Seas recently expanded its strategic partnership with Sagtec Global Limited, making it the exclusive AI development and technology partner for Sagtec across the Philippines, Malaysia, Indonesia, and Singapore. This move creates a powerful co-creation engine for the region's AI market and represents a major commercial milestone for the firm, providing an immediate and extensive channel to Sagtec's base of over 12,000 SaaS clients and transforming the Skilliks platform from a training and development environment into a primary driver of enterprise-grade AI solutions and recurring revenue. Their success in this endeavor will not only open the firm up to new growth and investment opportunities but also generate additional value for its stakeholders.

Kinetic Seas (KSEZ), closed Tuesday's trading session at $0.1005, up 10.4396%, on 195,000 volume. The average volume for the last 3 months is 212,143,639 and the stock's 52-week low/high is $0.0361/$0.85.

Cresco Labs Inc. (CRLBF)

CannabisNewsWire, QualityStocks, InvestorPlace, Kiplinger Today, Daily Trade Alert, MarketBeat, Cabot Wealth, Top Pros' Top Picks, The Street, The Wealth Report, Wealth Insider Alert, Trading For Keeps, Trades Of The Day, The Online Investor, Early Bird, Prism MarketView, StreetInsider, wyatt research newsletter, TradersPro and StocksEarning reported earlier on Cresco Labs Inc. (CRLBF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Cannabis remains illegal in Wisconsin, yet anyone driving through commercial districts could easily assume otherwise. Shops advertising CBD and THC products have multiplied across the state, filling windows with colorful displays of gummies, oils, drinks, and vape cartridges. Many grocery stores and gas stations also carry similar items. 

Their presence stems from a gap in federal law that allowed hemp products with trace levels of the psychoactive compound THC to be sold openly. That gap is now on track to close. 

A policy change in 2018 removed hemp from the federal list of controlled substances. The move permitted a wide range of products that include THC, provided they came from hemp and stayed under a strict limit of 0.3% by dry weight. The change fueled a booming market that a national hemp organization values at roughly $28 billion. 

President Donald Trump recently signed legislation to end the federal government shutdown. Tucked inside the measure was language that tightens the limit on THC levels in hemp products. Products containing more than 0.4 milligrams of THC would be barred, a standard that would rule out most products currently on store shelves. The new limit becomes enforceable in one year. 

This sparked immediate concern among growers, manufacturers, and retailers in Wisconsin, who fear the move could wipe out a large share of their business. Still, some legal scholars say the reaction may be stronger than the situation warrants. 

Robert Mikos, a professor at Vanderbilt University who studies drug policy, said the federal government lacks the capacity to enforce a sweeping crackdown on the wide network of companies that produce or sell these products. In his view, the future of the market will hinge largely on decisions made in states rather than Washington. 

Efforts to create state-level oversight are already moving. As the House prepared to vote on the shutdown legislation, Wisconsin’s Assembly Committee on State Affairs reviewed a bipartisan measure that would set up a thorough regulatory structure for hemp products. 

The proposal calls for mandatory testing and licensing, taxes similar to those on alcohol, and clear municipal authority. It also outlines an age requirement for purchasing and using these products, a licensing system for producers and retailers, and rules for packaging. 

A separate proposal would revise Wisconsin’s definition of hemp to match the new federal standard. That measure is expected to face a veto from Governor Tony Evers. 

Even so, Mikos said the industry is unlikely to face aggressive enforcement in the near future, even after the federal limit takes effect next year. He cautioned that small businesses could still encounter ripple effects involving taxes or federal permits. But he added that the risk of criminal penalties remains extremely low. 

Marijuana companies, such as Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF), will be tracking how this change to federal law impacts companies that have been manufacturing THC products from hemp. 

Cresco Labs Inc. (CRLBF), closed Tuesday's trading session at $0.8032, off by 10.257%, on 1,050,224 volume. The average volume for the last 3 months is 10,491,448 and the stock's 52-week low/high is $0.4256/$1.62.

Annovis Bio (ANVS)

BioMedWire, QualityStocks, SmallCapRelations, MissionIR, SeriousTraders, InvestorBrandNetwork, Stocks to Buy Now, Tip.us, NetworkNewsWire, StocksToBuyNow, SmallCapSociety, RedChip, TradersPro, Schaeffer's, MarketBeat, MarketClub Analysis, The Wealth Report, InvestorPlace, InsiderTrades, Red Chip, BUYINS.NET, INO Market Report, FreeRealTime, Mega Stock Alerts, Daily Trade Alert, OTCtipReporter, Penny Pick Finders, PennyStockProphet, 360 Wall Street, Profitable Trader Authority, Zacks, StockMarketWatch, StockOnion, StreetInsider, The Online Investor, Timothy Sykes and PennyStockScholar reported earlier on Annovis Bio (ANVS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Annovis Bio (NYSE: ANVS) a late-stage clinical drug platform company developing therapies for neurodegenerative diseases including Alzheimer’s and Parkinson’s, announced that the FDA has scheduled a Type C meeting in January 2026 to discuss the clinical pathway for buntanetap in Parkinson’s disease dementia. The Company also reaffirmed continued progress in its Phase 3 Alzheimer’s trial, which remains in full regulatory alignment on design, endpoints and patient population. CEO Maria Maccecchini said the meeting marks an important milestone for the PDD program, with Senior VP Cheng Fang noting that strong data across Alzheimer’s and Parkinson’s studies highlights buntanetap’s potential to address a major unmet need for cognitive decline in Parkinson’s patients.

To view the full press release, visit https://ibn.fm/G7zKh

About Annovis Bio Inc.

Headquartered in Malvern, Pennsylvania, Annovis is dedicated to addressing neurodegeneration in diseases such as AD and PD. The Company is committed to developing innovative therapies that improve patient outcomes and quality of life. For more information, visit www.annovisbio.com and follow us on LinkedIn , YouTube , and X .

Annovis Bio (ANVS), closed Tuesday's trading session at $3.37, up 11.2211%, on 7,205,610 volume. The average volume for the last 3 months is 175,562 and the stock's 52-week low/high is $1.11/$7.52.

Standard Lithium Ltd. (SLI)

QualityStocks, SeriousTraders, MiningNewsWire, MissionIR, NetworkNewsWire, SmallCapRelations, InvestorBrandNetwork, Stocks to Buy Now, Green Energy Stocks, BillionDollarClub, Rocks & Stocks, TinyGems, Tip.Us, StocksToBuyNow, SmallCapSociety, InvestorPlace, StreetInsider, MarketBeat, MarketClub Analysis, Top Pros' Top Picks, Daily Trade Alert, The Online Investor, Schaeffer's, Stockhouse, Louis Navellier, Trades Of The Day, Stock Bully and Millennium-Traders reported earlier on Standard Lithium Ltd. (SLI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

This article has been disseminated on behalf of Standard Lithium Ltd. and may include paid advertising.

Standard Lithium (NYSE American: SLI) , a near-commercial lithium company, will take part in several upcoming investor events, including the virtual Deutsche Bank Lithium and Battery Supply Chain Conference on Nov. 20, 2025, and the virtual Bank of America Critical Materials Conference on Nov. 24, 2025. CEO David Park will also speak at Citi’s Basic Materials Conference in New York on Dec. 3, 2025, at 10:50 a.m. ET, with live and replay access available through the Company’s investor relations site.

To view the full press release, visit https://ibn.fm/ZvV6o

About Standard Lithium

Standard Lithium is a leading near-commercial lithium development company focused on the sustainable development of a portfolio of large, high-grade lithium-brine properties in the United States. The Company prioritizes projects characterized by high-grade resources, robust infrastructure, skilled labor, and streamlined permitting. Standard Lithium aims to achieve sustainable, commercial-scale lithium production via the application of a scalable and fully integrated DLE and purification process. The Company’s flagship projects are located in the Smackover Formation, a world-class lithium brine asset, focused in Arkansas and Texas. In partnership with global energy leader Equinor, Standard Lithium is advancing the SWA Project, a greenfield project located in southern Arkansas, and actively advancing a promising lithium brine resource position in East Texas.

Standard Lithium Ltd. (SLI), closed Tuesday's trading session at $3.68, up 6.9767%, on 4,976,311 volume. The average volume for the last 3 months is 322,930 and the stock's 52-week low/high is $1.08/$6.4.

Off The Hook YS Inc. (OTH)

We reported earlier on Off The Hook YS Inc. (OTH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Off The Hook YS (NYSE American: OTH) , a premier yacht and boat wholesaler, closed its initial public offering of 3,750,000 shares at $4.00 per share for gross proceeds of $15 million, before underwriting discounts and expenses, and granted underwriters a 45-day option to purchase up to 562,500 additional shares; proceeds will be used to service the floorplan, advertise and market inventory, repay a promissory note and provide working capital, and ThinkEquity served as sole book-running manager for the offering.

To view the full press release, visit https://ibn.fm/9TdrA

About Off The Hook YS Inc.

Off The Hook is a premier yacht and boat wholesaler specializing in the buying and selling of yachts and boats. Off The Hook combines advanced technology, proprietary AI-assisted valuation tools, and a data-driven sales platform to bring greater transparency and efficiency to yacht transactions. Over the past decade, Off The Hook has become a go-to wholesaler in the marine industry, earning numerous accolades, having been named one of the 500 fastest-growing companies in the United States by Inc. 500 for two consecutive years, and is consistently ranked as a Top 100 Dealer in the USA by Boating Industry magazine. Today, Off The Hook generates over $90 million in annual boat and yacht sales, operating across eight locations with a team of over 35 sales representatives who transact on more than 400 vessels each year. The Company’s success is built on a commitment to excellence, emphasizing the hiring of highly skilled professionals who embody integrity and a passion for the boating industry. By prioritizing relationship-building and ensuring client satisfaction, Off The Hook believes that it has established the Company as the go-to wholesaler in the industry.

For more information, please visit the Company’s website: https://www.offthehookyachts.com/

Off The Hook YS Inc. (OTH), closed Tuesday's trading session at $3.26, off by 3.8348%, on 73,544 volume. The average volume for the last 3 months is 1,179,957 and the stock's 52-week low/high is $3.085/$3.9.

XTI Aerospace (XTIA)

Premium Stock Alerts, QualityStocks, The Online Investor, RedChip, Premium Stock Picks and MarketClub Analysis reported earlier on XTI Aerospace (XTIA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

XTI Aerospace (NASDAQ: XTIA) , a leader in vertical flight technologies and developer of the TriFan 600 VTOL aircraft, has acquired Drone Nerds, one of the largest U.S.-based drone distributors, in a $40 million transaction finalized Nov. 10, 2025, while simultaneously securing a $25 million strategic investment from Unusual Machines (NYSE American: UMAC) to accelerate growth in unmanned aircraft systems and the Vertical Economy(TM). Drone Nerds, with more than $100 million in 2024 revenue, brings hardware, software, and enterprise drone services to XTI through a mix of cash, promissory notes, and equity consideration, while the preferred stock investment from Unusual Machines awaits shareholder approval for conversion; leadership from all three companies emphasized the opportunity created by increasing demand for domestic UAS solutions following the June 2025 White House Executive Order on U.S. drone development, and XTI noted that ThinkEquity served as exclusive M&A advisor and placement agent for the transactions.

To view the full press release, visit https://ibn.fm/He7w9

About XTI Aerospace, Inc.

XTI Aerospace is revolutionizing aviation with its TriFan 600 xVTOL aircraft, combining helicopter-like vertical takeoff with the speed and range of a fixed-wing plane. The company also offers real-time location systems (RTLS) through its Inpixon business unit.

For more information, please visit the Company’s website: https://xtiaerospace.com/

XTI Aerospace (XTIA), closed Tuesday's trading session at $1.53, up 15.9091%, on 1,284,778 volume. The average volume for the last 3 months is 309,999 and the stock's 52-week low/high is $0.96/$60.

The QualityStocks Company Corner

D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

Cities and transport agencies across the U.S. are testing a wave of AI tools as they confront aging roads and a long backlog of repairs. From the Pacific Islands to large mainland states, officials are seeking faster, more accurate ways to track hazards and determine which issues require immediate attention. In Hawaii, for instance, officials are giving drivers free dashboard cameras to curb a recent rise in deadly crashes. Traffic deaths in the state rose this year, reaching 106 by October, already surpassing 2024. AI analysts say these early programs signal what is coming. Many expect that most new vehicles within the next decade will be equipped with cameras, whether they are driven by people or operated autonomously. With many entities like D-Wave Quantum Inc. (NYSE: QBTS) racing to bring to market even more sophisticated tech solutions, the range of tools available to state and local governments to address the challenges they face will definitely increase. 

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer

 

With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service

 

D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

  • Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
  • Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
  • Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Tuesday's trading session at $22.93, up 0.4380201%, on 27,543,933 volume. The average volume for the last 3 months is 50,616,577 and the stock's 52-week low/high is $1.435/$46.75.

Recent News

Massimo Group (NASDAQ: MAMO)

The QualityStocks Daily Newsletter would like to spotlight Massimo Group (NASDAQ: MAMO).

Massimo Group (NASDAQ: MAMO) , a manufacturer and distributor of powersports and electric vehicles, received retail and dealer orders exceeding 4,000 units for delivery over the next two months, representing more than $20 million in revenue expected to be reflected in Q4 results. The Company is rolling out holiday promotions across UTVs, ATVs and youth models, with strong early responses from dealers and major retail partners driven by the launch of its 2026 model year lineup. CEO David Shan said the team is focused on finishing the year strong as Massimo's growing retail footprint and emphasis on value and dependability continue to build momentum heading into 2026.

To view the full press release, visit https://ibn.fm/9k3z9

Massimo Group (NASDAQ: MAMO) is a prominent manufacturer and distributor specializing in powersports vehicles and recreational watercraft. Established in 2009, the company has built a reputation for delivering value-packed utility terrain vehicles (UTVs), all-terrain vehicles (ATVs), and on-road vehicles to both recreational enthusiasts and professionals in the agricultural sector. In 2020, Massimo expanded its offerings by launching Massimo Marine, dedicated to crafting high-quality watercraft with advanced designs and exceptional customer service.

Massimo Group is focused on sustainability. Its recent initiatives, including the introduction of the MVR Series of electric carts, highlight the company’s commitment to eco-friendly solutions that address growing consumer demand for sustainability in the powersports and marine industries.

The company’s manufacturing capabilities have also evolved significantly. Its expanded 376,000-square-foot facility in Garland, Texas, now features advanced automation, including a vehicle assembly robot line. This addition is expected to significantly enhanced production capacity and efficiency, enabling Massimo to scale its operations and better meet market demand.

Product Portfolio

Massimo Group’s product portfolio showcases its dedication to innovation and versatility. Its diverse lineup combines advanced features, sustainability, and value to meet the needs of a dynamic market.

  • Massimo Motor: This category includes a wide range of UTVs, ATVs, go-karts, and mini-bikes designed for both recreational and practical applications. Notable recent additions include the T-Boss 1000 UTV, which combines rugged performance with advanced features, and the GKD 350 All-Terrain Go-Kart, a versatile two-seater ideal for various terrains. The Buck 550-6 Crew, a six-seater UTV, further expands this lineup, providing comfort and utility for families and light-duty users at an accessible price point.
  • Massimo Marine: Specializing in pontoon and tritoon boats, this division emphasizes luxury and performance. A recent collaboration between Massimo and Vision Marine Technologies has introduced electric pontoon platforms, catering to consumers seeking eco-friendly watercraft for both commercial and recreational use.
  • Massimo Electric: Reflecting the company’s commitment to sustainability, Massimo Electric focuses on low-speed electric vehicles (LSVs) tailored for diverse applications. Recent launches include the MVR 2X Golf Cart and MVR Cargo Max Utility Cart, which deliver advanced features and versatility for recreational users and professionals in industries like farming and groundskeeping.

By combining practicality with cutting-edge design, Massimo Group seeks to set the standard in the powersports and marine industries.

Market Opportunity

The global ATV and UTV market is experiencing robust growth, with North America projected to reach approximately $9.18 billion in 2024 and expand at a compound annual growth rate (CAGR) of 7.8% to $13.37 billion by 2029, according to Mordor Intelligence. Likewise, the U.S. electric UTV and ATV powertrain market is rapidly expanding. It was valued at $2.46 billion in 2022 and is expected to grow at a CAGR of 10.2%, reaching $5.18 billion by 2030, as reported by Grand View Research.

The pontoon boat market complements this growth, driven by increased interest in leisure and marine tourism. The market size exceeded $7.9 billion in 2022 and is projected to grow at a CAGR of 8.3% through 2032, according to Global Market Insights. Massimo Marine’s introduction of electric pontoon platforms through its Vision Marine partnership is expected to position the company to effectively address this growing market segment.

With strategic partnerships and an expanding dealer network, Massimo believes it is poised to penetrate deeper into domestic and international markets. The company’s service coverage currently includes over 2,800 retail locations, 600 motor service centers, and 5,500 marine service centers, ensuring robust support and accessibility for customers. This extensive distribution network underpins Massimo’s ability to capture market share and drive sustained growth.

Leadership Team

David Shan, Founder, Chairman, and CEO, established Massimo Motor in 2009 and Massimo Marine in 2020. He has led the company through significant growth phases, including the development of diverse product lines and its public listing. Shan holds a bachelor’s degree in international trade from Qingdao Ocean University of China.

Dr. Yunhao Chen, CPA, serves as the company’s Chief Financial Officer, bringing extensive experience in capital markets, financial reporting, and corporate governance since her appointment in May 2023. She holds a Ph.D. in Accounting and an MBA in Finance from the University of Minnesota.

Michael Smith, Vice President, joined Massimo in 2019 and played a pivotal role in launching Massimo Marine. With a strong background in powersports retail and product innovation, he is dedicated to driving new product development. Smith studied International Business and Marketing at the University of California, San Diego.

Investment Considerations
  • Massimo Group operates within a large and growing total addressable market that’s projected to surpass $18 billion by 2026.
  • The company’s cost-competitive and feature-rich products, including all-electric offerings, provide a strong value proposition.
  • Recent automation initiatives at its Texas factory are expected to improve manufacturing efficiency by an estimated 50%.
  • During the first three quarters of 2024, revenue increased by 20.8% to $91.2 million compared to the same period in 2023, reflecting strong market demand and successful product launches.
  • Strategic partnerships, such as those with Vision Marine and Rural King, enhance Massimo’s market reach and growth opportunities.
  • Consistent innovation, as seen in the launches of the T-Boss 1000 and MVR Series, is expected to drive Massimo’s push to be a leader in its industry.

Massimo Group (NASDAQ: MAMO), closed Tuesday's trading session at $3.81, up 8.8571%, on 337,810 volume. The average volume for the last 3 months is 38,587 and the stock's 52-week low/high is $1.839/$4.48.

Recent News

Soligenix Inc. (NASDAQ: SNGX)

The QualityStocks Daily Newsletter would like to spotlight Soligenix Inc. (NASDAQ: SNGX).

For a while, the media has been filled with claims that vaccines cause autism. These claims have been amplified by public figures like the U.S. Secretary of Health & Human Services, R. F. Kennedy Jr., as well as other public health leaders. Now a parent, Greg Scaduto, whose child is autistic, has come out to explain why such thinking is misguided and does more harm than good. He explains that these false narratives are founded in a failure to understand the difference between correlation and causation. He says many people quickly, and falsely, jump to the conclusion that when two trends occur at the same time, one must be causing the other.  He says numerous studies have been conducted to establish whether vaccination causes autism but no concrete proof has been found in the different countries like Denmark, the U.S. and other developed countries where such rigorous studies have been undertaken for several decades. It is therefore important for public health officials to stick to evidence-based findings when informing the public about important matters instead of substituting scientific facts with political or personal views. As more voices join that of Greg Scaduto in clearing the air about these unsubstantiated claims or fallacies mistaking correlation for causation, entities like Soligenix Inc. (NASDAQ: SNGX) that focus on developing novel vaccines against numerous biothreats will be strengthened to ramp up their R&D programs geared at helping humanity deal with the threats posed by rampaging infectious diseases. 

Soligenix Inc. (NASDAQ: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases with high unmet medical needs. Operating through two key segments, the company’s Specialized BioTherapeutics division is dedicated to oncology and inflammation therapies, while its Public Health Solutions segment advances vaccines and therapeutics targeting biothreats and infectious diseases.

The company is actively advancing multiple late-stage clinical programs, including HyBryte™ (SGX301), a novel photodynamic therapy for cutaneous T-cell lymphoma (CTCL). Additional candidates in development target psoriasis (SGX302), oral mucositis (SGX942), and Behçet’s disease (SGX945), while its public health efforts focus on heat-stable vaccines for ricin poisoning (RiVax®), Ebola (SuVax™), and Marburg (MarVax™) viruses, that have been supported by non-dilutive government grants and contracts of approximately $60 million to date.

With a diversified pipeline, multiple orphan and fast-track designations, and collaborations with government agencies, Soligenix is uniquely positioned for potential regulatory approvals and commercialization.

The company is headquartered in Princeton, New Jersey.

Pipeline and Development Programs

Specialized BioTherapeutics

Soligenix’s Specialized BioTherapeutics division develops treatments for oncology and inflammatory diseases, focusing on conditions with few or no effective therapeutic options. HyBryte™ (synthetic hypericin) has completed a Phase 3 study for CTCL, demonstrating statistically significant efficacy, and a second confirmatory Phase 3 trial is actively enrolling patients to support potential regulatory submissions worldwide. If approved, it would be the first non-mutagenic photodynamic therapy for early-stage CTCL, addressing an unmet medical need. It has received orphan drug designations in the U.S. and Europe, as well as Fast Track designation in the U.S.

SGX302, a photodynamic therapy based on the same active ingredient as HyBryte™, is in clinical development for mild-to-moderate psoriasis, with positive Phase 1/2 proof-of-concept results, it is actively enrolling patients in a Phase 2a clinical trial.

SGX942, designed to reduce inflammation and tissue damage in oral mucositis associated with cancer treatment, is progressing as a potential first-in-class therapy.
SGX945, targeting aphthous ulcers in Behçet’s disease, is actively enrolling in a Phase 2a clinical trial and has received fast-track designation, highlighting the urgency of developing effective treatments for this rare inflammatory condition.

Public Health Solutions

The company’s Public Health Solutions segment focuses on medical countermeasures for biothreats and emerging infectious diseases, leveraging non-dilutive government funding to advance its programs. RiVax®, a ricin toxin vaccine, has demonstrated strong preclinical and early clinical results and may be eligible for government procurement under the Strategic National Stockpile initiative.

The company’s RiVax®, as well as its vaccine candidates for Ebola and Marburg viruses are based on its proprietary ThermoVax® technology, which stabilizes vaccines for long-term storage without refrigeration. This approach could be transformative in regions where maintaining cold-chain logistics is challenging.

The ongoing development of these vaccines is supported by funding from NIH, BARDA, and DTRA, with the potential for up to three priority review vouchers (PRVs) upon regulatory approval, to be used for future programs or sold. Notably, PRVs have previously sold for roughly $100 million.

Market Opportunity

Soligenix targets markets with significant commercial potential, focusing on rare diseases and biodefense applications. HyBryte™ addresses CTCL, a disease affecting over 68,000 patients across the U.S. and Europe, with a total market opportunity exceeding $250 million. SGX302, the company’s therapy for mild-to-moderate psoriasis, serves a much larger population, as over eight million people in the U.S. are affected by the condition, representing a global market opportunity exceeding $1 billion.

SGX942, developed for oral mucositis in head and neck cancer patients, is aimed at a market worth more than $500 million, while SGX945 for Behçet’s disease serves a niche segment valued at over $200 million worldwide.

In addition to its rare disease programs, Soligenix’s Public Health Solutions division has the potential to generate significant revenue through government procurement contracts. By focusing on both orphan drug markets and government-funded biodefense initiatives, Soligenix has positioned itself for sustained revenue growth through multiple high-value opportunities.

Leadership Team

Christopher J. Schaber, PhD, Chairman, President & CEO, brings to the company more than 35 years of experience in the biopharmaceutical industry. Before joining Soligenix, he held senior and operational leadership roles at Discovery Laboratories, Acute Therapeutics, Ohmeda Pharmaceuticals, The Liposome Company, and Wyeth Ayerst Laboratories. He has extensive expertise in drug development, regulatory affairs, and corporate strategy, positioning him to drive Soligenix’s growth and advancement toward commercialization.

Richard Straube, MD, Chief Medical Officer, has more than 35 years of experience in drug development and clinical research. Prior to joining Soligenix, he held key leadership roles at Stealth Peptides, INO Therapeutics, Ohmeda Pharmaceuticals, and Centocor. Throughout his career, he has played a crucial role in bringing innovative therapies to market, particularly in inflammatory diseases and immunology, making him a valuable asset in advancing Soligenix’s late-stage clinical programs.

Oreola Donini, PhD, Chief Scientific Officer, has more than 20 years of experience in pharmaceutical research and development, with expertise in immunology, inflammation, and rare diseases. Before joining Soligenix, she held leadership positions at Inimex Pharmaceuticals, ESSA Pharma, and Kinetek Pharmaceuticals, where she worked on novel drug discovery and translational medicine. Her experience in preclinical research and product development supports Soligenix’s continued innovation in biopharmaceuticals.

Jonathan Guarino, CPA, CGMA, Chief Financial Officer, has over 25 years of experience in corporate finance and strategic financial planning. Before joining Soligenix, he held financial leadership positions at Hepion Pharmaceuticals, Covance, BlackRock, and Barnes & Noble. His expertise in financial management, accounting, and capital markets plays a critical role in Soligenix’s financial strategy and operational efficiency.

Investment Considerations
  • Soligenix has multiple late-stage assets with orphan and fast-track designations, providing a clear regulatory pathway toward potential approvals.
  • The company’s pipeline has a total addressable market exceeding $2 billion, spanning rare diseases, inflammation, and biothreat applications.
  • Soligenix has benefited from significant non-dilutive government funding, which reduces operational expenses and financial risk while supporting its public health initiatives.
  • The company is well-positioned for multiple development and regulatory catalysts, and commercial milestones, with lead candidates in cutaneous T-cell lymphoma, psoriasis, oral mucositis, and Behçet’s disease.
  • Soligenix is led by an experienced management team with a strong track record of success.

Soligenix Inc. (NASDAQ: SNGX), closed Tuesday's trading session at $1.37, up 1.4815%, on 246,848 volume. The average volume for the last 3 months is 287,328 and the stock's 52-week low/high is $1.09/$6.2299.

Recent News

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF)

The QualityStocks Daily Newsletter would like to spotlight LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF).

LaFleur Minerals, Canadian gold exploration and development company, just launched a confirmation drilling program at its Swanson Gold Deposit in Val-D'Or, Quebec, supporting a Preliminary Economic Assessment ("PEA") for the restart of gold production at the company's Beacon Gold Mill

The campaign will work to validate historical results on the property while improving confidence in the geological model of the area

The 10-hole twinned-drilling campaign will supply fresh core for ore-sorting and metallurgical test work, with the data feeding directly into an updated Mineral Resource Estimate

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0), Canadian gold exploration and development company is advancing the district-scale Swanson Gold Project in Québec's prolific Abitibi Gold Belt while in parallel is progressing toward the near-term restart of gold production at its wholly owned Beacon Gold Mill, and recently launched a confirmation drilling program at its Swanson Gold Deposit in Val-D'Or. LaFleur is strategically positioned for near-term gold production and strong valuation upside, with its fully permitted Beacon Gold Mill and Swanson Gold Project in Val-d'Or, one of the world's premier mining camps now seeing major consolidation. With both of LaFleur's assets in the heart of the Abitibi greenstone belt, Canada's largest gold producing region that is also recently subject to major M&A action (IAMGOLD, Probe/Fresnillo), LaFleur offers exceptional leverage to record gold prices and growing regional demand for long-life, low-risk gold assets, with key regional, fully-permitted, infrastructure in a growing production corridor. LaFleur is in a unique position to offer critical milling services to area gold miners with their Beacon Gold Mill, providing important cash flow for the company's developing gold mining prospects. This timely milestone comes when gold prices continue to enhance the economics of the company's restart plans, promising strong margins, accelerated payback potential, and immediate exposure to cash flow from permitted, near-term production assets (https://ibn.fm/ZE8Xh).

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) is a Canadian exploration and development company advancing the district-scale Swanson Gold Project in Québec’s prolific Abitibi Gold Belt and progressing toward the near-term restart of gold production at its wholly owned Beacon Gold Mill. The company’s strategy centers on consolidating strategic land packages—highlighted by its flagship Swanson Gold Project, a 160 km² district-scale property that includes several prospects rich in gold and critical metals previously held by Monarch Mining, Abcourt Mines, and Globex Mining. The company is leveraging its 100%-owned, fully permitted and recently refurbished Beacon Gold Mill to transition from explorer to near-term gold producer—a key inflection point that typically triggers a market re-rating, further bolstered by current rising gold market prices. By processing material from Swanson and offering custom milling to regional projects, LaFleur aims to generate cash flow with minimal capital outlay, targeting annual gold production of up to 15,000 to 20,000 ounces by early 2026.

LaFleur’s vision is to evolve into an intermediate gold producer by capitalizing on strong market conditions and Québec’s rich mining infrastructure. The location, in the world-class Abitibi Gold Belt, and its infrastructure advantage, positions LaFleur for regional consolidation, strategic partnerships, or acquisition interest. Its mission emphasizes efficient value creation through methodical exploration, low-cost asset advancement, and opportunistic acquisitions—including land and deposits from Monarch Mining, Abcourt Mines, and Globex Mining.

Québec ranks among the world’s top mining jurisdictions, offering access to flow-through capital and regulatory stability. LaFleur’s integrated strategy—combining exploration at Swanson, a permitted mill at Beacon, and potential custom milling agreements—supports a streamlined path to near-term production.

LaFleur Minerals is headquartered in Vancouver, British Columbia.

Projects

LaFleur Minerals’ operations focus on two strategically located assets in the Abitibi Gold Belt: the Swanson Gold Project and the Beacon Gold Mill and Mine. These projects leverage the region’s world-class mining infrastructure and high-grade gold potential to drive the company’s transition to production.

Swanson Gold Project

The Swanson Gold Project spans 16,600 hectares and hosts the Swanson, Bartec, and Jolin gold deposits along a major structural break in the Abitibi Gold Belt. The 2024 Mineral Resource Estimate for the Swanson deposit outlines 123,400 oz of gold in Indicated category (2.1 million tonnes at 1.8 g/t) and 64,500 oz in Inferred category (872,000 tonnes at 2.3 g/t). Located 66 km north of Val-d’Or, the Project is accessible by road and rail and benefits from more than 36,000 meters of historical drilling, along with existing infrastructure including an 80-meter decline portal.

Recent work—including airborne magnetics, soil sampling, and Induced Polarization surveys—has identified multiple high-priority targets and resulted in several high-grade gold assay results, including a grab sample grading 11.71 g/t Au at Jolin, which points to significant upside as the Company prepares to test multiple new zones.

LaFleur has defined over 50 drill targets at Swanson and nearby prospects (Bartec, Jolin, Marimac) and is completing a minimum 5,000-metre diamond drilling beginning in June 2025. LaFleur Minerals has also initiated permitting for a 100,000-tonne surface bulk sample averaging 1.89 g/t Au, which it plans to process at the Beacon Gold Mill as part of a near-term production strategy.

Beacon Gold Mill

LaFleur’s 100%-owned Beacon Gold Mill is a fully refurbished and permitted mill and tailings storage facility capable of processing 750 tonnes per day (tpd), with potential expansion to 1,800 tpd, with access to numerous nearby gold deposits that could be prime sources of ore. Located only 60 km from Swanson, it underwent a $20 million upgrade by Monarch Mining in 2022 and has been under care and maintenance since early 2023. LaFleur is finalizing a C$5-6 million restart plan, ramping up production by late 2025 into early 2026, processing Swanson mineralized material and assessing custom milling opportunities for regional deposits, creating multiple potential revenue streams.

The Beacon Gold Mill is a de-risked, proven asset that benefits from existing infrastructure, including access to roads, power, and skilled labor, and further enhances the overall value proposition of LaFleur by providing a clear path to production and potential revenue-generation.

Market Opportunity

LaFleur Minerals is targeting the gold mining and processing market in Québec’s Abitibi Gold Belt, one of the world’s most productive gold regions. Its fully permitted Beacon Gold Mill, with a 750 tpd capacity and authorization to process 1.8 million tonnes of tailings, is strategically positioned to handle material from LaFleur’s Swanson Gold Project and to offer custom milling for nearby deposits such as Granada Gold. The company projects annual production of over 30,000 ounces of gold once in full production, with potential for significant revenue generation based on prevailing market prices.

Global demand for gold remains robust, driven by geopolitical risk, inflation hedging, and central bank accumulation. The World Gold Council forecasts 3-5% annual demand growth through 2030, with average prices expected between $3,200 and $3,500/oz. Within this environment, Québec’s top-tier mining jurisdiction—ranked fifth globally by the Fraser Institute in 2023—offers streamlined permitting and access to flow-through capital. LaFleur’s low-cost Beacon restart (C$5-6 million) and proximity to more than 100 active and historical mines position the company to fill a growing need for small-to-medium scale custom milling.

At Swanson, LaFleur plans to grow its current 187,900-ounce resource toward 1 million ounces through its 2025 drilling program. This hub-and-spoke strategy, leveraging centralized milling and strong local infrastructure, reduces development risk and strengthens LaFleur’s foothold in one of the most attractive gold belts in the world.

Leadership Team

Kal Malhi, Chairman, is a successful entrepreneur and the Founder of Bullrun Capital Inc., where he has raised over $300 million for early-stage companies across the mining, oil and gas, biomedical, agriculture, and technology sectors. He specializes in advancing academic research into commercial ventures and public listings, with more than two decades of capital markets and leadership experience.

Paul Ténière, M.Sc., P.Geo., Chief Executive Officer, is a seasoned mining executive and Professional Geologist with over 25 years of global experience in the development of precious and base metals, critical minerals, and metallurgical coal projects. Mr. Ténière is an expert in NI 43-101 and S-K 1300 disclosure standards and has held senior roles including President & CEO, SVP Exploration, and Director with several publicly traded mining companies. Mr. Ténière also worked at the Toronto Stock Exchange (TSX) and TSX Venture Exchange as a mining expert and Senior Listings Manager listing dozens of mining companies and ensuring listed issuers met their corporate governance and compliance and disclosure requirements.

Harry Nijjar, Chief Financial Officer and Corporate Secretary, serves as Managing Director at Malaspina Consultants Inc., providing CFO and strategic financial advisory services to companies across multiple industries. He holds a CPA CMA designation from the Chartered Professional Accountants of British Columbia and a Bachelor of Commerce from the University of British Columbia.

Louis Martin, P.Geo., Technical Advisor and Exploration Manager, is a veteran geologist with more than 40 years of exploration experience. He has played key roles in significant gold and base metal discoveries, including the Louvicourt (1989) and West Ansil (2005) deposits—both recognized by the Association de l’Exploration Minière du Québec (AEMQ). He previously served as VP Exploration at Clifton Star Resources, where he led the pre-feasibility study for the 4.5 million-ounce Duparquet Gold Project. He is a registered geologist in Québec and Ontario.

Tara Asfour, Corporate Communications, Investor Relations and Strategy, is an experienced executive consultant with over 12 years of management, investor relations, communications and marketing experience, specialized in capital markets. In her previous positions, Ms. Asfour has led over US$550 million worth of fundraising and strategic development initiatives. Ms. Asfour holds a Master’s degree in Business Management, a Financial Markets Certificate from Yale University, and a Certificate in Alternative Investments from HBS. Previous positions include investor relations executive at Red Pine Exploration, Fancamp Exploration, Communications Director at Dominion Water Reserves (now Prime Drink Group Corp) and advisor to various other publicly listed firms in the resource and technology sectors. Ms. Asfour holds the Institute for Governance (IGOPP) Certification in Governance, Ethics in Business Environment and Corruption Prevention.

Peter Espig, Strategic Advisor and Consultant, has served as Vice-President at Goldman Sachs Japan in both the Principal Finance and Securitization Group and the Asia Special Situations Group, where his team participated in more than $10 billion in structured deals, capital raises, and cross-border transactions. Prior to Goldman Sachs, he was Vice-President at Olympus Capital, a New York-based private equity firm, where he focused on corporate restructurings, investment analysis, and international financing negotiations. He also played a pioneering role in some of the earliest SPAC transactions, totaling over US$1.2 billion, and brings deep experience in disciplined capital deployment and turnaround execution. Since 2013, Mr. Espig has served as President and CEO of Nicola Mining Inc. and is a board member of ESGold Corp and First Lithium Minerals. Mr. Espig holds a Bachelor of Arts from the University of British Columbia and an MBA from Columbia Business School, where he was a Chazen International Scholar. He has served on various public boards and was recognized among Industry Era’s “Top 10 Admired Leaders” in 2023.

Jean Lafleur, Senior Technical Advisor, is a Professional Geologist (Québec) with 45 years of experience in Canada and internationally including USA, Mexico, Latin America, Ireland, Spain and Africa. Earlier in his career he worked with Newmont, Falconbridge, Dome Mines, and Placer Dome and has been a C-suite executive for a number of junior exploration companies. Jean has remained active as a technical, management, and financing consultant with junior explorers since the early 2000’s through his own geological consultancy firm and throughout his career has led a number of teams in the discovery of precious and base metals, nickel, PGE’s, uranium, and iron deposits. Jean’s expertise includes mining company and project evaluations, audits, technical reporting, exploration program planning and execution, and research and development with a strong focus on Québec. Jean currently acts as a Senior Consultant, North America for Appian Capital Advisory LLP, a mining-focused private equity firm based in London, UK where through his extensive professional network he sources and presents potential mining transactions in North America to the Appian team for investment opportunities.

Investment Considerations
  • LaFleur Minerals’ fully permitted Beacon Gold Mill, acquired in 2024 and refurbished by its previous owner, offers a low-cost path to production with an estimated restart budget of C$5-6 million.
  • The Swanson Gold Project’s 2024 mineral resource estimate of 123,400 oz indicated and 64,500 oz inferred, alongside a 5,000-meter drilling program, supports the company’s goal of growing the resource toward 1 million ounces.
  • Consolidation of 15,290 hectares, including acquisitions from Monarch Mining, Abcourt Mines, and Globex Mining, has positioned LaFleur as a formidable exploration company in the Abitibi Gold Belt.
  • LaFleur’s hub-and-spoke development model, centered on its Beacon Mill, supports custom milling opportunities and enhances value from regional partnerships.
  • A highly experienced leadership team with over 100 years of combined expertise across mining, finance, and capital markets underpins the company’s transition from exploration to production.

LaFleur Minerals Inc. (OTCQB: LFLRF), closed Tuesday's trading session at $0.4251, up 0.2121641%, on 16,210 volume. The average volume for the last 3 months is 83,120 and the stock's 52-week low/high is $0.021/$1.65.

Recent News

Micropolis Holding Co. (NYSE American: MCRP)

The QualityStocks Daily Newsletter would like to spotlight Micropolis Holding Co. (NYSE American: MCRP).

Micropolis (NYSE American: MCRP) is featured in the latest episode of IBN's TechMediaWire Podcast, where Founder and CEO Fareed Aljawhari discusses the company's evolution from autonomous police patrols to a broad robotics and AI platform delivering customized unmanned ground vehicles. Aljawhari details Micropolis' modular design approach, based on its M1 and M2 platforms, enabling tailored solutions for municipalities, oil and gas, defense and other sectors. He also highlights the company's trusted collaboration with Dubai Police, including advanced behavior-analysis software and autonomous patrol robots safely deployed in public environments, reinforcing Micropolis' role as a growing leader in AI-driven security technology.

To view the full press release, visit https://nnw.fm/Nwz6R

Micropolis (NYSE American: MCRP) , a UAE-based developer of autonomous mobile robots and AI-driven security solutions, launched a new industrial-grade, IP67-rated Edge Computing Unit powered by NVIDIA Orin SOC to deliver high-performance, low-latency AI processing directly on Microspot, its real-time surveillance and mission-management platform. Built for demanding environments with an IP67 enclosure, industrial connectivity and multiple GPU configurations up to 64 GB, the unit enables real-time computer vision, behavior analysis, suspect profiling and mission planning without reliance on cloud networks. CEO Fareed Aljawhari said the system ensures secure, on-device AI for law enforcement, border control and national security operations, while distributed edge networking allows Micropolis robots and fixed installations to share intelligence across wide areas for faster, more resilient autonomous decision-making.

To view the full press release, visit https://ibn.fm/ES1j9

Micropolis Holding Co. (NYSE American: MCRP) is a robotics and AI technology company pioneering the development of unmanned ground vehicles (UGVs), autonomous mobility platforms, and smart infrastructure for security, industrial, and urban applications. Since its founding in 2014, the company has evolved from a software startup into a fully integrated robotics manufacturer with expertise spanning mechatronics, embedded systems, AI software, and high-level autonomy. Its core technology is centered on modularity and adaptability, enabling Micropolis to deploy scalable robotics solutions across a wide range of industries and environments.

The company’s mission is rooted in a vision of harmonious human-machine collaboration, where intelligent automation drives sustainable progress. Through a growing portfolio of partnerships with public and private sector clients, including defense agencies, municipalities, and industrial operators, Micropolis aims to transform how the world approaches mobility, surveillance, and operational efficiency. These solutions are engineered not just to automate tasks, but to meaningfully enhance safety, sustainability, and strategic readiness in high-impact environments.

Following its initial public offering on the NYSE American in March 2025, Micropolis has accelerated the rollout of its autonomous platforms through regional pilots, strategic agreements, and ongoing R&D efforts.

The company is headquartered in Dubai, UAE.

Products

Micropolis offers a robust portfolio of autonomous robotics platforms, control systems, and AI software designed to meet the complex needs of security, industrial, and smart city applications.

M-Platform

Micropolis’ core robotics architecture is built around the M-Platform, a modular autonomous system composed of two primary components: a Mobility-Specific Platform (MSP) and an Application-Specific Pod (ASP). The MSP includes drive-by-wire and steer-by-wire systems, a custom suspension framework, and integrated power storage, all designed for durability and maneuverability in both urban and off-road environments. These platforms are compatible with a wide range of ASPs, enabling the same robotic base to be rapidly reconfigured for use cases in law enforcement, logistics, environmental cleanup, or public safety.

Advanced features across the platform include autonomous driving software, centralized control units, and AI-enhanced power management. Supporting technologies such as the Micropolis Robotic Control Unit (MRCU) and Smart Power Distribution Unit (SPDU) ensure high reliability, energy efficiency, and seamless integration with third-party systems. A compact mechanical design, high-precision control, and in-house R&D allow for scalable customization to match industry-specific requirements.

M-Patrol

The M-Patrol series includes specialized autonomous security and policing robots developed in collaboration with Dubai Police and other governmental entities. The M01 Patrol Unit is designed for open-road deployment, with speeds of 40–47 km/h and features like 360-degree AI vision, license plate recognition, crowd monitoring, and autonomous navigation. It is suited for high-traffic environments where rapid mobility and broad coverage are required.

The M02 Patrol Unit is built for enclosed or pedestrian-rich settings such as gated communities, offering a top speed of 7–10 km/h. It delivers low-speed, high-precision surveillance while maintaining safety in public-facing operations. In August 2025, Micropolis launched the final testing phase of the M02 platform in partnership with Dubai Expo City, Transguard Group, and Dubai Police. This pilot focused on validating advanced features including facial recognition, suspect tracking, behavior analysis, and autonomous navigation. Like the M01, the M02 is compatible with Micropolis’ proprietary command systems and can operate autonomously or under remote supervision.

Microspot

Microspot is Micropolis’ proprietary AI surveillance and analytics engine integrated into its robotic platforms. Initially co-developed with Dubai Police, Microspot enables real-time behavior analysis, facial recognition, and license plate detection through edge computing and machine learning algorithms. It is optimized for public safety use cases where rapid threat identification and decentralized processing are critical.

Micropolis’ recent agreement with AERXIO grants exclusive distribution rights of the company’s “Patrol” system, powered by Microspot, across Egypt and North Africa. This variant is engineered for border and desert operations, featuring a top speed of 50 km/h, a 15-hour runtime, and rapid charging capabilities. The integration of Microspot technology into these units allows for scalable deployment in both civilian and defense-oriented surveillance infrastructure.

Market Opportunity

Micropolis is strategically positioned to serve the growing demand for autonomous robotics and AI-powered systems across the Gulf Cooperation Council (GCC) and beyond. The company’s solutions address operational needs in urban security, logistics, defense, infrastructure, and environmental management—sectors that are undergoing rapid digital transformation in the Middle East.

Government initiatives in the UAE and Saudi Arabia have propelled the robotics and AI markets forward through funding, regulation, and institutional support. The UAE’s Strategy for Artificial Intelligence and Saudi Arabia’s Vision 2030 have created long-term national frameworks for automation and smart infrastructure adoption. Micropolis’ collaboration with public-sector partners, such as Dubai Police and SEE Holding’s Sustainable City 2.0, is aligned with these policy objectives and reflects growing national demand for autonomous technology.

Leadership Team

Fareed Aljawhari, Founder, Chief Executive Officer & Director, is a seasoned product designer and digital developer with over two decades of experience in Dubai’s digital transformation landscape. He founded Micropolis in 2014 and has led its evolution into a robotics and AI enterprise. He has cultivated strong relationships with government and private entities across the UAE, helping to position the company at the forefront of the region’s technology ecosystem.

Dzmitry Kastahorau, Chief Financial Officer, is a finance executive with international experience across the luxury retail, fashion, and automotive sectors. He holds a master’s degree in international corporate finance from EADA Business School in Barcelona and has previously held senior finance roles at Chalhoub Group, PUIG Spain, and Motherson Automotive in Germany.

Investment Considerations
  • Micropolis is a first-mover in AI-powered autonomous mobility within the GCC, backed by longstanding relationships with major public-sector stakeholders like Dubai Police.
  • Its vertically integrated platform architecture supports rapid product customization across a wide range of industries and operational use cases.
  • The company is actively expanding its footprint beyond the UAE through exclusive distribution agreements in Egypt and North Africa.
  • Multiple product lines, including robotics for security, sanitation, logistics, and environmental restoration, offer diversified growth pathways.
  • Recent IPO proceeds are being deployed into R&D, talent acquisition, and commercialization, accelerating the company’s path toward scaled global deployment.

Micropolis Holding Co. (NYSE American: MCRP), closed Tuesday's trading session at $1.23, off by 6.8182%, on 317,515 volume. The average volume for the last 3 months is 330,933 and the stock's 52-week low/high is $1.1134/$5.64.

Recent News

Newton Golf Company Inc. (NASDAQ: NWTG)

The QualityStocks Daily Newsletter would like to spotlight Newton Golf Company Inc. (NASDAQ: NWTG).

Newton Golf Company Inc. (NASDAQ: NWTG), a Sacks Parente Company, is a technology-forward golf equipment manufacturer committed to enhancing player performance through innovative design. Since its founding in 2018, the company has developed a growing portfolio of premium golf products, including putters, golf shafts, grips, and related accessories. Its proprietary advancements include the First Vernier Acuity putter, patented Ultra-Low Balance Point (ULBP) technology, weight-forward Center-of-Gravity (CG) design, and ultra-light carbon fiber putter shafts.

As part of its commitment to growth in golf shaft technologies, the company expanded its manufacturing operations in April 2022, opening a dedicated facility in St. Joseph, Missouri. This move reinforced its goal of maintaining high-quality production standards while manufacturing and assembling substantially all of its products in the United States. In addition to golf clubs and accessories, Newton Golf Company is exploring expansion into golf apparel and other product categories.

The company sells its products through multiple channels, including resellers, its direct-to-consumer website, Club Champion retail stores, and distributors in the U.S., Japan, and South Korea. Future expansion may include growth through mergers, acquisitions, or the development of complementary product lines.

Newton Golf Company is headquartered in Camarillo, California.

Products

Newton Golf Company is focused on delivering high-performance golf equipment with a strong emphasis on precision engineering and cutting-edge materials. The company’s key product lines include:

  • Newton Motion Golf Shafts: Launched in November 2023, these shafts are engineered with proprietary flex profiles designed for greater distance, reduced dispersion, and optimized performance across swing speeds. The company’s DOT system eliminates traditional shaft flex definitions, making it accessible to all golfers.
  • Gravity Putters: Introduced in October 2024, these putters incorporate patented Ultra-Low Balance Point (ULBP) technology to improve stroke consistency and tighten putt dispersion. Manufactured in the U.S., they feature premium materials such as steel, aluminum, titanium alloys, and patented magnesium face plate technology.
  • Golf Grips & Accessories: The company continues to innovate in this category, providing golfers with performance-enhancing grips and accessories to complement their clubs.

All Newton Golf Company products are manufactured with strict quality control standards to ensure precision and reliability, reinforcing the brand’s reputation for premium performance.

Market Opportunity

The global golf equipment market was valued at approximately $8 billion in 2022, with the U.S. market accounting for $2.9 billion. The golf club segment dominated the industry, representing 45.7% of total market share. Increasing participation in golf, particularly among younger players and women, is driving demand for high-quality, customizable golf equipment.

Key industry trends supporting growth include:

  • The increasing popularity of premium, high-performance golf equipment among both professionals and amateurs.
  • A shift toward customization, as golfers seek tailored products that enhance performance.
  • A growing interest in golf from younger demographics, with amateur and collegiate golfers being particularly receptive to innovation.

Newton Golf Company’s emphasis on U.S.-based manufacturing provides it with a competitive edge in terms of supply chain efficiency, quality control, and sustainability, further strengthening its position in the market.

Leadership Team

Dr. Greg Campbell, Executive Chairman and Chief Executive Officer, brings nearly 40 years of experience in emerging technologies, product development, and public company leadership. He currently serves as CEO of V-Grid Energy Systems, a California-based company focused on converting agricultural waste into renewable electricity and bio-carbon. He has successfully taken two companies public and previously managed a $1.2 billion P&L as SVP & GM at Lam Research. Campbell holds a Ph.D. in Electrical and Electronics Engineering from UCLA and a BA/MA in Engineering from Cambridge University.

Ryan Stearns, Chief Financial Officer, was appointed in 2024 and oversees financial planning and corporate strategy. He brings expertise in scaling businesses and optimizing financial performance to support the company’s growth.

Investment Considerations
  • Newton Golf Company operates in a large and expanding global golf equipment market with rising demand for high-performance products.
  • The company benefits from strong gross margins and a clear pathway to profitability as it scales its operations.
  • U.S.-based manufacturing provides strict quality control, supply chain efficiency, and faster response times to market demand.
  • An omnichannel sales strategy, including retail, e-commerce, and international distribution, enhances market reach and revenue diversification.
  • Future growth opportunities include new product lines, strategic acquisitions, and continued technological advancements in golf equipment.

Newton Golf Company Inc. (NASDAQ: NWTG), closed Tuesday's trading session at $1.15, up 27.1843%, on 341,634 volume. The average volume for the last 3 months is 108,427 and the stock's 52-week low/high is $0.82/$53.1.

Recent News

NRx Pharmaceuticals Inc. (NASDAQ: NRXP)

The QualityStocks Daily Newsletter would like to spotlight NRx Pharmaceuticals Inc. (NASDAQ: NRXP).

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders, with a particular emphasis on conditions characterized by acute suicidality. The company is leveraging its proprietary NMDA receptor modulation platform to address significant unmet medical needs in suicidal depression, bipolar depression, chronic pain, and post-traumatic stress disorder (PTSD).

With a commitment to advancing life-saving treatments, NRx is developing novel therapeutics aimed at providing safer and more effective alternatives to current treatment options. Its lead investigational drug, NRX-101, is positioned to be the first FDA-approved oral therapy for suicidal bipolar depression. Additionally, the company is working to bring NRX-100 (intravenous ketamine) to market as an approved treatment for acute suicidal depression, a condition for which existing treatments remain limited.

By integrating cutting-edge science with a patient-focused mission, NRx aims to transform the standard of care for individuals suffering from severe psychiatric and neurological conditions.

NRx has also established HOPE Therapeutics, a subsidiary focused on delivering interventional psychiatric care through a nationwide clinic network. HOPE Therapeutics aims to become the first coordinated system of care for suicidal depression and PTSD, combining ketamine, Transcranial Magnetic Stimulation (TMS), digital therapeutics, and other precision psychiatry tools in a supervised clinical environment.

NRx is headquartered in Wilmington, Delaware. HOPE is headquartered in Miami, Florida.

Product Portfolio

NRx Pharmaceuticals’ pipeline includes multiple late-stage therapeutic candidates targeting psychiatric and neurological disorders:

  • NRX-100: A preservative free intravenous ketamine formulation under development for acute suicidal depression, backed by strong clinical trial data and Fast Track designation from the FDA.
  • NRX-101: An oral therapy with a dual mechanism targeting NMDA and 5-HT2A receptors, designed for patients with suicidal treatment-resistant bipolar depression. The drug has received Breakthrough Therapy designation from the FDA.
  • Expanded Research: The company is further evaluating NRX-101 as a potential non-opioid treatment for chronic pain and a therapy for complicated urinary tract infections.

NRx’s therapeutic pipeline is designed to address conditions with limited or no treatment options, with the potential to improve patient outcomes and expand the standard of care.

HOPE Therapeutics

HOPE Therapeutics, a wholly owned subsidiary of NRx Pharmaceuticals, is establishing a national network of psychiatrist-led clinics focused on suicidal depression and PTSD. Its care model integrates preservative-free ketamine, TMS, digital therapeutics, and supervised psychiatric support to deliver rapid, measurable outcomes.

The company is targeting more than 30 clinic acquisitions by year-end 2025. Recent agreements include the acquisition of Dura Medical and a letter of intent with Neurospa TMS, strengthening HOPE’s foundation in interventional psychiatry. In April, HOPE also secured a term sheet for strategic investment from a global medical device manufacturer.

With ketamine sales already underway under a 503B license, HOPE projects $100 million in annual revenue and profitability by year-end 2025. Positioned as a standalone care delivery company, HOPE offers NRx a potential future spinout opportunity to unlock additional shareholder value.

Market Opportunity

The need for innovative treatments in mental health and pain management is substantial. Suicide is a leading cause of death in the United States, claiming nearly 50,000 lives each year, with over 12 million adults seriously considering suicide annually, according to the CDC.

Suicidal depression, a distinct and life-threatening condition, affects approximately 3.5 million Americans. Despite this prevalence, the only approved intervention remains electroconvulsive therapy (ECT), a treatment with significant side effects and limited access. NRx aims to address this urgent gap with NRX-100, a preservative-free intravenous ketamine formulation being developed as the first FDA-approved treatment specifically for suicidal depression.

Additionally, approximately 7 million Americans suffer from bipolar depression, a condition where nearly half of patients will attempt suicide during their lifetime and one in five may die by suicide. NRX-101, NRx’s oral drug candidate, targets this critical unmet need as a potential first-in-class therapy specifically for bipolar depression.

Beyond mood disorders, chronic pain affects over 50 million individuals in the U.S., and PTSD impacts more than 12 million people—conditions for which few non-opioid, fast-acting treatments are available. By addressing these high-risk, underserved populations, NRx Pharmaceuticals is positioned to enter multiple billion-dollar markets and reshape the standard of care for severe psychiatric and neurological illnesses.

Leadership Team

Jonathan C. Javitt, Founder, Chairman & Chief Executive Officer or NRx, and Co-CEO of HOPE, brings four decades of experience in pharmaceutical and medical device development. He has led blockbuster drug and device programs at major companies, including Allergan, Merck, and Novartis, and has served as an advisor to four U.S. presidential administrations.

Michael Abrams, Chief Financial Officer, has nearly 30 years of experience in finance, having served in executive roles, including CFO positions at Arch Therapeutics and FitLife Brands. His expertise spans investment banking, corporate finance, and business strategy.

Rick Panicucci, Chief Technology Officer, has more than 25 years of leadership in pharmaceutical manufacturing and process development. He has held key positions at Novartis, WuXi AppTec, and other major companies, leading multiple approved New Drug Applications.

Matthew Duffy, Chief Business Officer, NRx, Co-CEO of HOPE, has over 35 years of experience in biotechnology business development and investment banking. He has held leadership roles at Pfizer, MedImmune, and several financial institutions, specializing in corporate strategy and partnerships.

Investment Considerations
  • NRx Pharmaceuticals is advancing a pipeline of innovative therapies targeting significant unmet needs in central nervous system disorders.
  • The company’s lead candidate, NRX-101, has received FDA Breakthrough Therapy designation, expediting its development.
  • NRX-100 (preservative free IV ketamine) has been granted Fast Track designation by the FDA for acute suicidal depression a patent for this novel formulation has been filed with the US Patent and Trademark Office.
  • HOPE Therapeutics, NRx’s interventional psychiatry subsidiary, is targeting $100M in revenue by year-end 2025 through a national clinic network treating suicidal depression and PTSD.
  • The company’s experienced leadership team has a proven track record in pharmaceutical development and commercialization.
  • NRx is positioned to address large and growing markets with its novel depression treatments, non-opioid therapeutic solutions and directly help patients in HOPE clinics.

NRx Pharmaceuticals Inc. (NASDAQ: NRXP), closed Tuesday's trading session at $2.28, up 8.0569%, on 445,748 volume. The average volume for the last 3 months is 485,748 and the stock's 52-week low/high is $1.1302/$6.01.

Recent News

HeartBeam Inc. (NASDAQ: BEAT)

The QualityStocks Daily Newsletter would like to spotlight HeartBeam Inc. (NASDAQ: BEAT).

HeartBeam Inc. (NASDAQ: BEAT) is a medical technology company pioneering a new approach to cardiac care by delivering hospital-grade electrocardiogram (ECG) insights outside traditional clinical settings. Its proprietary platform supports a scalable app-based solution for real-time heart monitoring.

The company’s mission is to empower both patients and physicians with actionable cardiac data wherever symptoms begin, addressing a critical gap in the first hours of cardiac events. Through its connected cardiac care ecosystem, HeartBeam is establishing a new model for remote monitoring that deepens patient engagement and delivers more actionable insights for physicians. This approach is designed to obtain early diagnosis which could reduce time to treatment, improve outcomes, and lower costs across the healthcare continuum.

HeartBeam’s system aims to bring clinical-grade cardiac assessment into the home. HeartBeam is preparing for commercial launch as its 12-lead ECG synthesis software undergoes regulatory review, building on prior clearance of its 3D ECG system for arrhythmia assessment. The company plans to leverage its unique longitudinal ECG dataset and deep learning algorithms to advance predictive capabilities in the future.

HeartBeam is headquartered in Santa Clara, California.

Products

HeartBeam’s flagship innovation is its credit card-sized, cable-free ECG device that collects heart signals in three non-coplanar dimensions and synthesizes a 12-lead ECG. Cleared by the FDA in December 2024 for arrhythmia assessment, the HeartBeam System enables patients to capture high-fidelity heart data during symptomatic episodes, even outside a clinical environment.

The company’s pending 12-lead ECG synthesis software, developed from the same 3D signal acquisition, successfully met clinical endpoints in the VALID-ECG study and is currently under FDA review for arrhythmia assessment. This software combined with an on-demand cardiologist reader service is expected to form the backbone of HeartBeam’s commercial launch strategy, providing patients with access to a synthesized 12-lead ECG outside of the traditional hospital setting and enabling physician interpretation of patient ECGs from anywhere.

From the core, the team is building an ecosystem that includes integration with wearables, automated arrhythmia assessments, AI-driven wellness features, community features and trending insights. The ecosystem is intended to drive adoption and increase the overall value of the HeartBeam System.

Artificial Intelligence and Predictive Analytics

To enhance its diagnostic capabilities, HeartBeam is developing AI-powered arrhythmia detection algorithms to be validated in collaboration with Mount Sinai Heart. In early testing, these deep learning algorithms achieved diagnostic accuracy comparable to standard 12-lead ECGs when classifying atrial fibrillation, atrial flutter, and sinus rhythm.

Additionally, HeartBeam’s AI engine has the potential to transform routine monitoring into predictive power in the future. The company’s platform enables frequent readings, building a unique longitudinal ECG dataset unique that no one else offers. By leveraging deep learning on the repeated measurements, there is an opportunity to develop predictive capabilities, such as screening for hidden cardiac conditions and forecasting risk of future events. The unique longitudinal dataset will create a defensible data moat as the company continues to advance its AI program.

Market Opportunity

HeartBeam is targeting a large unmet need in cardiac care by delivering hospital-grade ECG diagnostics to patients outside of traditional healthcare settings. Cardiovascular disease is the leading cause of death worldwide, yet most cardiac events occur at home, where standard 12-lead ECGs are not available, leading to costly delays in diagnosis and treatment. HeartBeam’s FDA-cleared 3D ECG technology is designed to close this critical gap with on-demand, remote diagnostic capabilities.

The company’s initial commercialization strategy focuses on two distinct U.S. entry markets. The first includes approximately 500,000 elevated-risk patients in concierge care settings, representing a $250 million to $500 million annual revenue opportunity. The second addresses a larger direct-pay segment of 2.6 million elevated-risk individuals, with potential revenues of $1.3 billion to $2.6 billion annually. Future expansion may include reimbursement-driven pathways through Medicare Advantage, providers, and payer partnerships.

HeartBeam anticipates annual subscription pricing between $500 and $1,000 per patient, with roughly 50% gross margins on device costs and 70%+ on recurring revenue. Based on a model using five U.S. regions, each with an estimated 75,000 eligible patients, HeartBeam projects that just 10% adoption would generate approximately $20 million in gross profit—enough to reach cash flow break-even under current pricing and margin assumptions. Over time, the company’s longitudinal ECG dataset and predictive AI capabilities are expected to deliver additional value to healthcare systems, research institutions, and life science partners.

Leadership Team

Robert Eno, Chief Executive Officer and Director, brings over 30 years of experience in the medical technology industry, including leadership roles at HeartFlow, OptiMedica, and NeoGuide Systems. He joined HeartBeam as President in January 2023 and was appointed CEO in October 2024, later joining the board in May 2025 to support commercial growth.

Branislav Vajdic, Ph.D., Founder and Chief Technology Officer, is a semiconductor and medtech innovator who previously led product design teams at Intel and founded NewCardio. He holds over 20 patents and is the original architect of HeartBeam’s core technology.

Tim Cruickshank, Chief Financial Officer, oversees financial strategy and capital allocation. He works closely with the leadership team to support commercialization while maintaining financial discipline aligned with key regulatory milestones.

Peter Fitzgerald, M.D., Ph.D., Chief Medical Advisor, is Director of the Center for Cardiovascular Technology at Stanford and a seasoned clinical trialist with over 175 studies and 650 publications. He has founded over 20 medtech companies and advises the FDA on digital health analytics.

Ken Persen, Chief Technology Officer, has more than 28 years of experience in cardiac rhythm management and digital health. He previously served as CTO and CEO at LIVMOR and held engineering roles at Cameron Health and Guidant.

Investment Considerations
  • HeartBeam has developed and secured FDA clearance for a credit card-sized 3D ECG device that enables arrhythmia assessment outside of traditional clinical settings.
  • The company’s 12-lead ECG synthesis software successfully met pivotal study endpoints and is currently under FDA review, supporting near-term commercialization.
  • HeartBeam’s AI algorithms, validated in collaboration with Mount Sinai, demonstrated high diagnostic accuracy and provide a foundation for predictive cardiac monitoring. The company plans to submit its AI algorithms for FDA clearance in the future.
  • The company holds more than 20 issued patents, including protections for device design and risk-based diagnostic algorithms.
  • HeartBeam was honored with the 2025 Innovation Award in Remote Cardiac Diagnostics, reinforcing its leadership position in the digital health space.

HeartBeam Inc. (NASDAQ: BEAT), closed Tuesday's trading session at $1.7, up 10.3896%, on 99,093 volume. The average volume for the last 3 months is 80,459 and the stock's 52-week low/high is $0.9101/$3.48.

Recent News

SuperCom Ltd. (NASDAQ: SPCB)

The QualityStocks Daily Newsletter would like to spotlight SuperCom Ltd. (NASDAQ: SPCB).

SuperCom Ltd. (NASDAQ: SPCB) is a global provider of secure solutions spanning electronic monitoring, e-Government, and cybersecurity markets. Since 1988, the company has supported national governments and public agencies with advanced safety, identity, and tracking technologies. Its solutions enable courts, service providers, and public safety agencies to efficiently supervise high-risk populations, improve victims’ safety and manage compliance with judicial mandates across multiple jurisdictions.

SuperCom’s growth in North America has accelerated since mid-2024, with expansion into 11 new U.S. states and more than 30 contracts secured with public safety agencies and regional service providers, displacing long-standing incumbents in the process. This expansion reflects the company’s emphasis on recurring revenue, technological differentiation, and close partnership with agencies seeking innovative, mobile-first alternatives to outdated systems.

SuperCom’s vision is to revolutionize the public safety sector through proprietary electronic monitoring technology, data intelligence, and flawless execution. Its offerings include GPS and RF-based monitoring, biometric ID verification, mobile law enforcement tools, and national-level e-ID platforms.

The company is headquartered in Tel Aviv, Israel.

Products

Electronic Monitoring and Public Safety

SuperCom’s operations are anchored by its proprietary PureSecurity suite, a unified offender monitoring platform combining GPS tracking, biometric verification, tamper detection, and advanced data analytics. Its PureOne™ one-piece bracelet and PureTrack™ smartphone-integrated solution offer high-precision location tracking, real-time alerts, and seamless integration with PureCom™ base stations, PureBeacon™ indoor trackers, and PureProtect™, an app designed to safeguard domestic violence victims.

The company complements its hardware with PureMonitor™, a secure, cloud-based case management system that enables real-time oversight, mobile access, and data visualization for monitoring agencies. This full-stack approach allows SuperCom to support a range of court-mandated programs including GPS monitoring, house arrest, curfew enforcement, and community supervision. The company’s domestic violence monitoring solutions are now deployed in at least seven countries.

SuperCom’s U.S. subsidiary, Leaders in Community Alternatives (LCA), provides reentry and rehabilitation services that complement the company’s electronic monitoring programs. Operating primarily in California, LCA delivers community-based solutions designed to reduce recidivism and promote successful reintegration. Its programs include individualized case management, employment support, evidence-based treatment, and day reporting centers—services that support public safety while offering alternatives to incarceration. Since LCA’s acquisition in 2016, SuperCom secured over $35 million in new contract wins in Northern California.

Cybersecurity

SuperCom also offers additional capabilities through its cybersecurity and e-Government product lines. The company’s cybersecurity subsidiary, Safend Ltd., provides endpoint data protection through its Data Protection Suite. This platform includes modules for encryption (Encryptor), port/device control (Protector), data classification (Discoverer), DLP (Inspector), audit tracking (Auditor), and compliance reporting (Reporter).

e-Gov

Through proprietary e-government platforms and innovative solutions for traditional and biometrics enrollment, personalization, issuance, and border control services, SuperCom has helped governments and national agencies design and issue secured multi-identification documents and robust digital identity solutions to their citizens, visitors, and lands. The company has focused on expanding its activities, including the design, development, and marketing of identification technologies and solutions to governments in Europe, Asia, America, and Africa using SuperCom’s e-Government platforms.

Market Opportunity

SuperCom operates across multiple high-growth sectors. In electronic monitoring, rising incarceration costs, overcrowded prisons, and increased judicial adoption of alternatives to detention continue to drive demand for GPS and RF-based supervision programs. The company’s rapid expansion into 11 U.S. states and multiple national-level deployments in Europe and the EMEA region reflect a robust and growing market. According to Mordor Intelligence, the electronic offender monitoring solutions market size stands at $2.18 billion in 2025 and is projected to reach $3.19 billion by 2030.

SuperCom also addresses two important supplementary markets through its cybersecurity and e-Government offerings. In cybersecurity, growing threats to sensitive government and enterprise data are fueling investments in endpoint protection, compliance, and device control, which are areas directly served by the company’s Safend platform. In the public sector identity space, secure ID, biometric verification, and e-passport programs remain foundational to digital governance. SuperCom’s track record of delivering national ID solutions across Africa, Latin America, and Eastern Europe underscores its continued relevance in these adjacent sectors.

Leadership Team

Ordan Trabelsi is President and CEO of SuperCom. He has over 15 years of experience as CEO, growing high-tech companies globally. He also has experience in research and development and product innovation, as well as hands-on experience in cybersecurity, encryption, advanced mathematics, and mobile and internet network technologies. Prior to joining SuperCom, he served as co-founder and CEO of Klikot Inc., a global social networking company. He holds an MBA from Columbia University and a B.Sc. in Computer Engineering from The Technion: Israel Institute of Technology.

Barak Trabelsi is COO of SuperCom. He has expertise in big data, cyber, mobile, and internet network technologies, as well as extensive experience in product development and strategies. Prior to joining SuperCom, he served as Senior Product Manager at Equinox Ltd. Before that, he served for four years as VP of R&D at Sigma Wave, a wireless, security, and internet-focused company. He holds a B.Sc. in Computer Science and Business, as well as an MBA from Tel Aviv University.

Investment Considerations
  • SuperCom reported record net income of $5.3 million and non-GAAP EPS of $1.84 in the first half of 2025, reflecting strong financial performance.
  • The company has expanded into 11 new U.S. states since mid-2024, securing over 30 new electronic monitoring contracts and forming nine new provider partnerships.
  • Its recurring revenue model ensures consistent monthly billing based on unit count, promoting financial stability and predictability.
  • SuperCom operates across multiple high-growth sectors including public safety, national identity, and cybersecurity, offering diversified market exposure.
  • The company has a demonstrated ability to displace long-term incumbents and rapidly scale its solutions across new geographies.

SuperCom Ltd. (NASDAQ: SPCB), closed Tuesday's trading session at $8.69, up 3.3294%, on 69,861 volume. The average volume for the last 3 months is 89,100 and the stock's 52-week low/high is $3.08/$18.95.

Recent News

Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF)

The QualityStocks Daily Newsletter would like to spotlight Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF).

Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) is a Canadian mine development and exploration company advancing a portfolio of gold and silver assets in Nevada’s Walker Lane, one of the world’s most productive and mining-friendly regions. Through its U.S. subsidiaries, the company controls four gold and silver properties in Nevada, three of which are 100%-owned and one controlled via a low-cost option to acquire full ownership. With a clear near-term path to production, Lahontan is focused on unlocking oxide gold and silver value from past-producing, infrastructure-rich projects.

The company’s mission is to responsibly develop and expand its oxide resources while minimizing capital intensity and maximizing economic returns. Leveraging a strong technical team with a track record of advancing projects and building mines, Lahontan is focused on growing gold and silver resources and hitting permitting milestones across multiple sites. Its strategy prioritizes scalability, efficiency, and timely value realization for shareholders.

By maintaining full project ownership and a capital-light development model, Lahontan Gold is positioned to rapidly transition from development to production.

The company is headquartered in Toronto, Ontario.

Projects

Santa Fe Mine

The 26.4 km² Santa Fe Mine is Lahontan’s flagship asset and core development priority. A past-producing open-pit, heap-leach gold and silver operation, Santa Fe historically yielded more than 359,000 ounces of gold and 702,000 ounces of silver between 1988 and 1995. The site benefits from established infrastructure—including power, water, and road access—and more than 79% of its known resources are unencumbered by royalties.

A 2024 NI 43-101 resource estimate outlines 1.54 million ounces of gold equivalent (AuEq) in the Indicated category and 0.41 million ounces Inferred, all pit-constrained. Oxide resources average among the highest grades in the state and are distributed across five known deposits. A 2025 Preliminary Economic Assessment (PEA) projects strong economic returns, including an after-tax NPV5% of $200 million, a 34.2% internal rate of return (IRR), and average annual production of approximately 50,000 ounces AuEq over an eight-year mine life.

Permitting is well underway for both the Exploration and Mine Plans of Operation, covering over 12 km² and more than 700 drill holes. The company is targeting construction permits in late 2026 and continues to pursue oxide resource expansion and metallurgical optimization, particularly within the Slab-Calvada corridor.

West Santa Fe

West Santa Fe lies just 13 kilometers from the flagship and is being explored as a potential satellite operation. The project is defined by a shallow, oxide-dominant gold-silver system with a conceptual target of 0.5 to 1.0 million ounces AuEq based on historic drilling and recent surface sampling, which returned up to 2.61 g/t Au and 899 g/t Ag (14.6 g/t AuEq). A 6,300-meter Phase One reverse circulation drill program is scheduled for 2025 to validate historical data and support a maiden resource estimate. Development is streamlined under a low-cost option agreement and a rapid permitting path via Notice of Intent.

Moho and Redlich

The Moho and Redlich projects provide additional longer-term upside within Lahontan’s portfolio. Moho features high-grade, oxidized epithermal veins with historic production at grades of 20–25 g/t Au and 300 g/t Ag. A 2019 core drill program confirmed the presence of high-grade mineralization at depth. Redlich, located along trend from the historic Candelaria silver mine, hosts disseminated Ag mineralization in epithermal veins and hydrothermal breccias but remains untested by drilling. While no near-term programs are currently disclosed, both assets represent future exploration optionality.

Market Opportunity

Lahontan Gold operates in Nevada, consistently ranked the top global mining jurisdiction by the Fraser Institute due to its transparent permitting process, legal stability, and established infrastructure. Nevada produces over 4.5 million ounces of gold annually, generating approximately $9 billion in value, and ranks fifth globally in total gold production.

According to the World Gold Council, total gold demand in Q1 2025 reached 1,206 tonnes, up 1% year-over-year, marking the strongest first quarter since 2016. Central banks added 244 tonnes to reserves, a slight slowdown from the prior quarter but well within the strong buying range observed over the past three years. Meanwhile, silver demand is supported by strong industrial usage in solar panels, electric vehicles, and semiconductors, with long-term deficits forecast in the physical silver market.

With macro-driven demand for gold, technology-driven silver consumption, and strong institutional buying across both metals, Lahontan is uniquely positioned to capitalize through its portfolio of oxide-focused projects in a top-tier jurisdiction—offering near-term production potential and longer-term resource expansion.

Leadership Team

Kimberly Ann, Founder, CEO, President & Executive Chair, is a veteran mining executive with a track record of founding and scaling junior resource companies. She has raised over $210M in financing and led the $340M buyout of Prodigy Gold. Her prior roles include CFO of PPX Mining and founder of Latin America Resource Group, which merged with Carube Copper to form C3 Metals.

Brian Maher, Founder and VP of Exploration, is an economic geologist with more than 45 years of experience. He previously led Prodigy Gold as CEO, where he helped develop the Magino gold project before its $341M acquisition. His career includes senior roles at ASARCO, Hochschild Mining, and PPX Mining, where he oversaw exploration and production in the Americas.

John McNeice, Chief Financial Officer, is a Chartered Professional Accountant with three decades of experience in public company reporting. He has served as CFO for seven public resource companies and played a key role in Ur-Energy Inc.’s TSX IPO and $150M in financings. He also serves as CFO for Gold79 Mines, C3 Metals, and Northern Graphite Corp.

Current Initiatives
  • Commencing Summer gold and silver resource expansion drilling at Santa Fe
  • Optimizing Preliminary Economic Assessment reflecting +$3,000 gold price
  • Exploration Plan of Operations heading into NEPA stage with approval expected Q4 2025
  • Targeting late 2026 mining permit and breaking ground at Santa Fe in 2027
Investment Considerations
  • The Santa Fe Mine hosts 1.95 million ounces of pit-constrained gold equivalent resources across Indicated and Inferred categories.
  • A 2025 Preliminary Economic Assessment for Santa Fe outlines an after-tax NPV5% of $200 million and a 34.2% IRR based on spot pricing.
  • All four projects are 100%-owned or under low-cost acquisition agreements, with development centered in Nevada, the world’s top mining jurisdiction.
  • Near-term catalysts include Santa Fe permitting milestones, West Santa Fe’s maiden drill program, and an updated economic study.
  • The company is led by a proven team with multiple M&A exits and extensive experience in advancing heap-leach gold operations.

Lahontan Gold Corp. (OTCQB: LGCXF), closed Tuesday's trading session at $0.1039, up 4.004%, on 894,631 volume. The average volume for the last 3 months is 1,337,060 and the stock's 52-week low/high is $0.0143/$0.1675.

Recent News

Safe Pro Group Inc. (NASDAQ: SPAI)

The QualityStocks Daily Newsletter would like to spotlight Safe Pro Group Inc. (NASDAQ: SPAI).

Safe Pro Group Inc. (NASDAQ: SPAI) is a mission-driven technology company delivering advanced AI-powered security and defense solutions. It is focused on serving customers in the defense, homeland security, humanitarian, law enforcement, and commercial markets where its AI, drone-based services and ballistic protective gear can synergistically deliver safety and operational efficiency.

At the heart of Safe Pro’s mission is its patented artificial intelligence (AI), machine learning (ML), deep learning and applied computer vision software technology. These tools are currently being used to rapidly detect small objects in drone-based video and imagery such as landmines and unexploded ordnance (UXO), enabling safer and more efficient field operations across global conflict and post-conflict zones and supporting efforts to improve the reliability of critical infrastructure. The company’s vision is to lead the evolution of security and threat detection through AI innovation, while its mission is to empower governments, enterprises, and humanitarian organizations with tools to respond to evolving threats at scale.

With a team of leaders and subject matter experts drawn from the defense, technology, and public safety sectors, Safe Pro Group delivers U.S.-developed next-generation AI and drone services through its Safe Pro AI and Airborne Response units and high-performance, American-made ballistic protective solutions through its Safe-Pro USA subsidiary.

The company is headquartered in Aventura, Florida.

Products

Safe Pro Group’s three business units operate across software, hardware, and field services to deliver a comprehensive suite of solutions. Each division plays a distinct role in supporting defense, humanitarian and public safety missions around the world.

Safe Pro AI

Safe Pro AI’s core AI-powered computer vision technology enables the rapid analysis of drone-based imagery to autonomously detect objects of interest. Its flagship product, SpotlightAI™ can detect and label over 150 types of explosive threats including landmines, cluster munitions, and unexploded ordnance (UXO). Built on more than two years of real-world usage in Ukraine and now including additional imagery being gathered from the Asian-Pacific region and Africa, SpotlightAI™ rapidly processes and creates high-resolution maps supported by the hyper scalability of the Amazon Web Services (AWS) cloud or detects threats in real-time locally through its OnSite Windows-based software application. Today, the platform boasts one of the world’s largest datasets built on over 1.6 million real-world battlefield images from Ukraine, identifying 28,000+ threats across more than 6,750 hectares, an area equivalent in size to Manhattan.

Airborne Response

Airborne Response is a leading provider of mission critical drone services using U.S. Government-compliant small uncrewed aircraft systems (sUAS) (drones). It serves enterprises in utilities & telecom and insurance with a full-range of drone-based critical infrastructure inspection and monitoring solutions as well as Drone-as-a-First Responder (DFR) services for law enforcement and public safety. It provides customers with actionable intelligence though data capture, analytics and processing powered by AI.

Safe-Pro USA

Safe-Pro USA manufactures ultra-premium, American-made ballistic protection systems including advanced body armor and ballistic plates as well as complete Explosive Ordnance Disposal (EOD) suits, demining aprons, and bomb blankets. All products exceed U.S. and NATO standards and are designed, engineered, and produced in the U.S., supporting customers across military, humanitarian, and law enforcement sectors.

Market Opportunity

Harnessing its patented, real-time, AI-powered processing of drone-based imagery, Safe Pro is creating a uniquely powerful ‘Next-Gen’ approach to situational awareness supporting ground-based personnel in safely completing their defense/military, humanitarian, law enforcement & commercial missions.

The global threat posed by landmines and UXO spans nearly 60 countries, affecting millions of civilians and imposing significant economic burdens, particularly in agriculture and infrastructure. In Ukraine alone, the contamination of 17 million hectares has resulted in $50+ billion in agricultural losses, with World Bank estimates projecting $30 billion needed in demining costs. According to the Landmine Monitor 2024, regions in Asia, Africa, and Latin America continue to report high casualty rates.

Safe Pro is positioned to capture a portion of the $15 billion+ global defense tech market, especially in AI-driven battlefield intelligence, drone surveillance, and threat detection. As a U.S.-based AI and defense technology provider with a HUBZone-certified manufacturing arm, Safe Pro is eligible for federal and state procurement programs, public safety grants, and critical infrastructure contracts, as well as global humanitarian demining efforts.

Leadership Team

Dan Erdberg, Chairman and CEO, brings over 20 years of experience as a C-level technology executive. He has led multiple Nasdaq listings in the drone, 5G, and satellite communications sectors, raised over $50 million in growth capital, and spearheaded Safe Pro Group’s corporate strategy and acquisitions.

Theresa Carlise, Chief Financial Officer, has more than 30 years of experience in financial leadership roles for public companies. Her expertise includes equity transactions, strategic planning, and financial restructuring. She served as Chief Financial Officer, Secretary, Treasurer and Director of various publicly traded companies within the retail, telecommunications, distribution, transportation, mortgage banking and construction sectors.

Pravin Borkar, CTO and Director (President, Safe-Pro USA), has over 30 years of experience in the engineering and manufacturing of ballistic protection systems for the U.S. Department of Defense. He has developed armor solutions for personnel and aircraft platforms including the CH-53 and Blackhawk.

Christopher Todd, President (Airborne Response), is a drone industry veteran and Certified Emergency Manager (CEM®) with more than 30 years of experience. He founded Airborne Response and is President of AUVSI Florida, with expertise in public safety drone deployment and emergency response.

Investment Considerations
  • Unique, battle-tested and patented AI image analysis technology ready for commercialization in U.S. defense and public safety markets following more than 2 years of real-world usage in Ukraine.
  • Well positioned to capitalize on U.S. military’s increased strategic focus on domestically produced drone and AI technologies through integration with currently deployed platforms such as the U.S. Army’s Tactical Assault Kit (TAK) ecosystem for military force protection.
  • The patented SpotlightAI™ platform enables real-time detection of over 150 types of mines and UXO using AI and drone imagery and is now operating at scale, creating the world’s largest datasets of real-world landmines and UXO built on more than 1.6 million battlefield images processed and 28,000 threats identified.
  • Safe Pro is addressing a global, multi-billion-dollar need for scalable defense, public safety and demining solutions.

Safe Pro Group Inc. (NASDAQ: SPAI), closed Tuesday's trading session at $4.89, up 3.3827%, on 253,365 volume. The average volume for the last 3 months is 428,249 and the stock's 52-week low/high is $1.47/$9.1599.

Recent News

BluSky AI Inc. (OTC: BSAI)

The QualityStocks Daily Newsletter would like to spotlight BluSky AI Inc. (OTC: BSAI).

BluSky AI Inc. (OTC: BSAI) is pioneering the next generation of AI infrastructure through modular, rapidly deployable data centers that meet the escalating compute demands of artificial intelligence, machine learning, and high-performance computing. The company’s mission is to empower AI innovators by eliminating infrastructure bottlenecks and accelerating time-to-compute with energy-efficient, scalable solutions.

Rather than betting on individual AI applications, BluSky AI addresses the universal need for compute power—positioning itself as a foundational layer in the AI revolution. Its infrastructure-first approach enables clients to focus on innovation while the company delivers the critical backbone powering tomorrow’s breakthroughs.

BluSky AI is headquartered in Salt Lake City, Utah.

Products

BluSky AI’s core offering is its SkyMod series of modular data centers—pre-assembled, scalable compute units designed specifically for AI workloads. The flagship SkyMod One delivers 1 MW of compute power in a compact 1,400-square-foot footprint, while the SkyMod XL offers 1.7 MW in 3,000 square feet. These units are fully assembled off-site, tested, and shipped ready for plug-and-play deployment either on BluSky-owned land or client facilities.

SkyMod modules integrate NVIDIA GPUs and are optimized for high-density AI applications such as generative AI, large language models, inference engines, and scientific computing. Built for rapid scaling and high efficiency, each system includes advanced cooling, secure infrastructure, and dynamic workload balancing to support evolving client needs.

The company’s data centers are engineered for sustainability, incorporating renewable energy sources like solar, wind, and geothermal where available. By deploying on powered land assets, BluSky AI shortens lead times and lowers costs, creating a fast, flexible alternative to traditional monolithic data centers.

Market Opportunity

The global data center market was valued at $347.6 billion in 2024 and is projected to reach $652.0 billion by 2030, growing at a CAGR of 11.2%, driven by the rapid expansion of AI, machine learning, and IoT adoption, according to Grand View Research. As enterprises demand faster, more scalable compute solutions, modular infrastructure like BluSky AI’s SkyMod series offers a compelling alternative to legacy data center models.

With North America accounting for over 40% of the global market and the U.S. expected to grow at a 10.7% CAGR from 2025 to 2030, BluSky AI is well-positioned to capture demand for AI-optimized infrastructure that can be deployed rapidly and cost-effectively. By focusing on GPU-centric, modular deployments tied to energy infrastructure, the company addresses a growing gap between compute demand and deployment speed in the AI era.

Leadership Team

Trent D’Ambrosio, Chief Executive Officer, is a seasoned executive with a track record in telecommunications, hedge fund management, and natural resource development. He previously sold the first transatlantic fiber cable, built a successful gold mining company, and now leads BluSky AI with a vision to revolutionize AI infrastructure through strategic energy integration and rapid deployment.

Julien Bedard, Chief Technology Officer, is a pioneering technologist known for launching the first Bitcoin escrow and anti-fraud service. At BluSky AI, he oversees cloud architecture, cybersecurity, infrastructure automation, and the development of AI-native data center technology, ensuring scalability and resilience across deployments.

Dan Gay, Chief Operating Officer, has Fortune 500 executive leadership in telecom, technology, and energy, as well as start-up experience with finance and blockchain companies. At MCI and Qwest, he launched new service and sales centers, and directed National Account Sales. He has been a successful CMO in brand creation, product development, partnerships, and revenue generation programs to expand company awareness, sales, and revenue.

Investment Considerations
  • BluSky AI delivers mission-critical infrastructure supporting AI, ML, and HPC applications.
  • SkyMod modules are prefabricated, scalable, and optimized for rapid plug-and-play deployment.
  • The company’s data center designs emphasize sustainability with support for renewable energy.
  • BluSky’s infrastructure-first model addresses universal AI compute needs across industries.
  • A veteran leadership team combines expertise in telecom, finance, and advanced technologies.

BluSky AI Inc. (OTC: BSAI), closed Tuesday's trading session at $4.13, up 4.557%, on 630 volume. The average volume for the last 3 months is 1,090 and the stock's 52-week low/high is $0.118/$17.97.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.